The bitter battle between the Federal Trade Commission and LabMD over the agency’s charges that the company failed to provide reasonable security to protect consumers’ sensitive personal information will soon return...
Subscription required to view this article.
This content can only be accessed by FTCWatch subscribers. If you are an FTCWatch subscriber, please login to access this content
If you do not currently subscribe to FTCWatch please contact us for subscription information: